BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35916994)

  • 1. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
    Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer.
    Ushitani Y; Shimada Y; Yamada Y; Kudo Y; Yamada T; Tanaka T; Ohira T; Ikeda N
    Ann Surg Oncol; 2022 Oct; 29(11):6922-6931. PubMed ID: 35729292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer.
    Takahashi M; Sakamoto K; Kogure Y; Nojiri S; Tsuchiya Y; Honjo K; Kawai M; Ishiyama S; Sugimoto K; Nagakari K; Tomiki Y
    BMC Cancer; 2024 Jun; 24(1):741. PubMed ID: 38890682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer.
    Shinohara S; Otsuki R; Kobayashi K; Sugaya M; Matsuo M; Nakagawa M
    Ann Surg Oncol; 2020 Jul; 27(7):2427-2435. PubMed ID: 31970570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
    Gen Thorac Cardiovasc Surg; 2019 Nov; 67(11):949-954. PubMed ID: 30972530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
    Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
    J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Akazawa A
    PLoS One; 2021; 16(9):e0257594. PubMed ID: 34551011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Sarcopenia and Metabolic PET-CT Parameters on Survival in Locally Advanced Non-Small Cell Lung Carcinoma.
    Karaman E; Hursoy N; Goksel S
    Nutr Cancer; 2023; 75(1):286-295. PubMed ID: 35959787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
    Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification based on skeletal muscle mass and the severity of lung emphysema impacts on clinical outcomes after anatomical resection for lung cancer.
    Tsubokawa N; Mimura T; Tadokoro K; Yamashita Y
    Jpn J Clin Oncol; 2022 Aug; 52(8):917-924. PubMed ID: 35438159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer.
    Hervochon R; Bobbio A; Guinet C; Mansuet-Lupo A; Rabbat A; Régnard JF; Roche N; Damotte D; Iannelli A; Alifano M
    Ann Thorac Surg; 2017 Jan; 103(1):287-295. PubMed ID: 27659598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer.
    Nakada T; Noda Y; Kato D; Shibasaki T; Mori S; Asano H; Matsudaira H; Hirano J; Odaka M; Ohtsuka T
    Thorac Cancer; 2019 Oct; 10(10):1945-1952. PubMed ID: 31436042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
    Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
    Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
    Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
    Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
    Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
    Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of 18 F-FDG PET/computed tomography metabolic parameters in predicting sarcopenia and prognosis of treatment-naive patients with non-small cell lung cancer.
    Li D; Tan X; Yuan H; Yao X; Sun X; He L; Jiang L
    Nucl Med Commun; 2023 Apr; 44(4):309-317. PubMed ID: 36756769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is radiological psoas muscle area measurement a predictor of postoperative complications after rectal resection for rectal cancer? A retrospective study.
    Uehara H; Yamazaki T; Iwaya A; Kameyama H; Utsumi S; Harada R; Komatsu M; Hirai M; Kubota A; Katada T; Kobayashi K; Sato D; Yokoyama N; Kuwabara S; Otani T
    Surg Today; 2022 Feb; 52(2):306-315. PubMed ID: 34309711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.